133 related articles for article (PubMed ID: 21922418)
1. Prodrug design for brain delivery of small- and medium-sized neuropeptides.
Prokai-Tatrai K; Prokai L
Methods Mol Biol; 2011; 789():313-36. PubMed ID: 21922418
[TBL] [Abstract][Full Text] [Related]
2. Large amino acid transporter 1 (LAT1) prodrugs of valproic acid: new prodrug design ideas for central nervous system delivery.
Peura L; Malmioja K; Laine K; Leppänen J; Gynther M; Isotalo A; Rautio J
Mol Pharm; 2011 Oct; 8(5):1857-66. PubMed ID: 21770378
[TBL] [Abstract][Full Text] [Related]
3. A prodrug nanoparticle approach for the oral delivery of a hydrophilic peptide, leucine(5)-enkephalin, to the brain.
Lalatsa A; Lee V; Malkinson JP; Zloh M; Schätzlein AG; Uchegbu IF
Mol Pharm; 2012 Jun; 9(6):1665-80. PubMed ID: 22574705
[TBL] [Abstract][Full Text] [Related]
4. Prodrugs of thyrotropin-releasing hormone and related peptides as central nervous system agents.
Prokai-Tatrai K; Prokai L
Molecules; 2009 Feb; 14(2):633-54. PubMed ID: 19214153
[TBL] [Abstract][Full Text] [Related]
5. Prodrugs of peptides. 6. Bioreversible derivatives of thyrotropin-releasing hormone (TRH) with increased lipophilicity and resistance to cleavage by the TRH-specific serum enzyme.
Bundgaard H; Møss J
Pharm Res; 1990 Sep; 7(9):885-92. PubMed ID: 2122435
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic and ulcerogenic studies of naproxen prodrugs designed for specific brain delivery.
Sheha M
Arch Pharm Res; 2012 Mar; 35(3):523-30. PubMed ID: 22477200
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and biological evaluation of glutathione peptidomimetics as components of anti-Parkinson prodrugs.
More SS; Vince R
J Med Chem; 2008 Aug; 51(15):4581-8. PubMed ID: 18651729
[TBL] [Abstract][Full Text] [Related]
8. Brain uptake of ketoprofen-lysine prodrug in rats.
Gynther M; Jalkanen A; Lehtonen M; Forsberg M; Laine K; Ropponen J; Leppänen J; Knuuti J; Rautio J
Int J Pharm; 2010 Oct; 399(1-2):121-8. PubMed ID: 20727958
[TBL] [Abstract][Full Text] [Related]
9. Evidence for interplay between thyrotropin-releasing hormone (TRH) and its structural analogue pGlu-Glu-Pro-NH2 ([Glu2]TRH) in the brain: an in vivo microdialysis study.
Nguyen V; Zharikova AD; Prokai L
Neurosci Lett; 2007 Mar; 415(1):64-7. PubMed ID: 17234338
[TBL] [Abstract][Full Text] [Related]
10. Improved brain delivery of a nonsteroidal anti-inflammatory drug with a synthetic glyceride ester: a preliminary attempt at a CNS drug delivery system for the therapy of Alzheimer's disease.
Deguchi Y; Hayashi H; Fujii S; Naito T; Yokoyama Y; Yamada S; Kimura R
J Drug Target; 2000; 8(6):371-81. PubMed ID: 11328663
[TBL] [Abstract][Full Text] [Related]
11. [Synthesis of prodrugs of tacrine hydrochloride and evaluation of the stability and biodistribution in mice].
Jiang Y; Zhang Y; Zhang ZR
Yao Xue Xue Bao; 2003 Dec; 38(12):962-5. PubMed ID: 15040096
[TBL] [Abstract][Full Text] [Related]
12. L-type amino acid transporter 1 utilizing prodrugs of ferulic acid revealed structural features supporting the design of prodrugs for brain delivery.
Puris E; Gynther M; Huttunen J; Auriola S; Huttunen KM
Eur J Pharm Sci; 2019 Mar; 129():99-109. PubMed ID: 30625368
[TBL] [Abstract][Full Text] [Related]
13. Centrally acting and metabolically stable thyrotropin-releasing hormone analogues by replacement of histidine with substituted pyridinium.
Prokai L; Prokai-Tatrai K; Zharikova AD; Nguyen V; Perjesi P; Stevens SM
J Med Chem; 2004 Nov; 47(24):6025-33. PubMed ID: 15537357
[TBL] [Abstract][Full Text] [Related]
14. Prodrugs to enhance central nervous system effects of the TRH-like peptide pGlu-Glu-Pro-NH2.
Prokai-Tatrai K; Nguyen V; Zharikova AD; Braddy AC; Stevens SM; Prokai L
Bioorg Med Chem Lett; 2003 Mar; 13(6):1011-4. PubMed ID: 12643900
[TBL] [Abstract][Full Text] [Related]
15. Metabolism-based brain-targeting system for a thyrotropin-releasing hormone analogue.
Prokai L; Prokai-Tatrai K; Ouyang X; Kim HS; Wu WM; Zharikova A; Bodor N
J Med Chem; 1999 Nov; 42(22):4563-71. PubMed ID: 10579819
[TBL] [Abstract][Full Text] [Related]
16. Distribution and quantitation of the anti-trypanosomal diamidine 2,5-bis(4-amidinophenyl)furan (DB75) and its N-methoxy prodrug DB289 in murine brain tissue.
Sturk LM; Brock JL; Bagnell CR; Hall JE; Tidwell RR
Acta Trop; 2004 Jul; 91(2):131-43. PubMed ID: 15234662
[TBL] [Abstract][Full Text] [Related]
17. Novel brain targeting prodrugs of naproxen based on dimethylamino group with various linkages.
Zhang Q; Liang Z; Chen LY; Sun X; Gong T; Zhang ZR
Arzneimittelforschung; 2012 Jun; 62(6):261-6. PubMed ID: 22407924
[TBL] [Abstract][Full Text] [Related]
18. [Studies on synthesis and properties of N-benzoyl-THA targeting for brain].
Gong T; Zhang Z; Liu L
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Feb; 21(1):21-4. PubMed ID: 15022455
[TBL] [Abstract][Full Text] [Related]
19. Enkephalin analog prodrugs: assessment of in vitro conversion, enzyme cleavage characterization and blood-brain barrier permeability.
Greene DL; Hau VS; Abbruscato TJ; Bartosz H; Misicka A; Lipkowski AW; Hom S; Gillespie TJ; Hruby VJ; Davis TP
J Pharmacol Exp Ther; 1996 Jun; 277(3):1366-75. PubMed ID: 8667199
[TBL] [Abstract][Full Text] [Related]
20. Glucose promoiety enables glucose transporter mediated brain uptake of ketoprofen and indomethacin prodrugs in rats.
Gynther M; Ropponen J; Laine K; Leppänen J; Haapakoski P; Peura L; Järvinen T; Rautio J
J Med Chem; 2009 May; 52(10):3348-53. PubMed ID: 19402664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
